Julian Upton

Understanding markets, influencers, and patients through better stakeholder engagement and faster analysis

A conversation with dangerous goods expert Jay Johnson

AZ’s Greg Rossi talks about the company’s oncology activities and his vision for the future of cancer treatment

In this Q&A, Kristian Sibilitz, senior vice president, pharmaceutical production & supply chain at Lundbeck, outlines the impact of the last 2+ years on the Danish drugmaker’s supply chain activities

Surya Gummadi discusses the partnership between global IT company Cognizant and pharma company Organon, for which Cognizant is providing the technology to combat supply chain challenges

The HOSP Alliance‘s Gary Kerr on adding another level of value to the packaging and delivery of dispensed drugs and modifying terminology

A look at the supply chain issues pertinent to the generics industry

Chandra Briggman talks about her achievements and future plans as president and CEO of Activation Capital, which supports local and regional efforts to grow a high-growth entrepreneurship community in the Richmond, VA area

New report explores what trends may lie ahead for pharma supply chains

Pharma Commerce's podcasts offer new angles on its roster of key topics

Exploring the competitive and unique offerings in three of the US’s lower-cost economic development regions—and how success in these areas has been boosted by COVID

A look into one of the East Coast’s major life science hubs

Contract sales organizations are evolving alongside the companies they serve

A look into the effectiveness of data processing pipelines

General manager Tom Bostwick tells the story behind the new digital pharmacy, Birdi.

Tips for navigating the obstacles surrounding product launch

How did the industry get here and what alternatives can be sought out?

Willis Chandler, AmerisourceBergen’s recently named President of Biopharma Services, Strategic Global Sourcing and Commercial Solutions, talks about the new investments AB is making to build out its capabilities and its new cell and gene therapy service line.

A conversation with ZS’s Maria Whitman and Anshul Agarwal

The Health System Owned Specialty Pharmacy (HOSP) Alliance‘s Melissa Goff responds to the news of the FTC investigation into PBM practices news and outlines the alliance‘s vision for the integrated specialty pharmacy industry

A reflection on the industry's effort to foster and facilitate sustainability

A conversation with EY life sciences leaders Jim Welch and Jay Welsh

Maria Whitman, global head of ZS’s pharmaceutical and biotech practice, talks about the upheaval of the pharma business model and what it means for sales reps; the current skills gap in the marketplace; and how mega-mergers could soon be back on the agenda

EVERSANA CEO Jim Lang discusses the organization’s continuing rise in an industry that has seen seismic changes taking place

Biopharma firm strives to deliver savings to the US healthcare system

Graham Cromb, Vice President of Europe Operations at UPS Healthcare talks about how the COVID-19 pandemic fueled UPS’ expansion in Europe, and where the company is heading in the post-COVID landscape

How this link in the supply chain can help alleviate healthcare challenges

How a company empowers HCPs through its consolidated supply chain system

PC's new editor-in-chief details his thought process on familiarizing himself with a different side of the industry

New book attempts to cut through pharma’s patient-centric posturing and start a conversation about real, transformational change